Elevexo® Skin
Elevexo® S : Science-Driven Skin Renewal
Exosome Skin Treatment & Growth Factor Serum for Skin Rejuvenation
How Exosome Skin Treatment Works — The Science
Exosomes for Skin — What the Research Shows
Interest in exosomes for skin has grown rapidly as research continues to explore their role in regeneration and repair. Exosomes act as carriers of growth factors and signalling molecules that support the skin’s natural renewal processes — helping to promote a healthy environment for collagen production, hydration, and cellular turnover. Published research referenced on this page, including sources on EGF and PDRN, points to the regenerative potential of these signalling compounds when applied in a professional setting.
As an exosomes skin treatment, Elevexo® S brings this science into clinical practice, combining a panel of growth factors and peptides selected for their supporting roles in skin regeneration. For clinics, this research-backed foundation strengthens both treatment rationale and patient confidence.
Growth Factor Serum for Clinics — Key Benefits
A professional growth factor serum is fundamentally different from the growth factor products marketed to consumers. Elevexo® S is formulated exclusively for clinical use, delivering a concentrated, standardised panel of growth factors and peptides at potencies appropriate for administration by licensed professionals. This makes it a reliable foundation for skin rejuvenation treatment protocols where consistency and quality are essential.
For clinics, the key benefits are clear. First, professional-grade formulation: every batch is produced under strict manufacturing standards, ensuring predictable composition and performance. Second, targeted action: the serum’s growth factors and biomimetic peptides work together to support collagen synthesis, elasticity, and overall skin renewal. Third, protocol versatility: Elevexo® S integrates into a range of in-clinic treatments, from standalone application to combination procedures.
Unlike consumer serums, which are limited by over-the-counter formulation constraints, a clinical growth factor serum is designed to complement professional procedures and deliver results that align with a clinic’s standards. For practices offering skin rejuvenation treatment, Elevexo® S provides a science-led, professional-tier option that supports both clinical outcomes and patient satisfaction.
Collagen & Elastin Synthesis
Collagen and elastin are the structural proteins responsible for skin firmness, elasticity, and a youthful appearance. Within the Elevexo® S formulation, growth factors such as EGF and IGF-1 play a supporting role in signalling the fibroblasts that drive collagen and elastin production. By reinforcing these natural signalling pathways — described in the growth factor section above — the serum helps support the skin’s structural renewal from within, contributing to improved texture, resilience, and tone over the course of a treatment protocol.
5 Growth Factors for Skin Rejuvenation Treatment (EGF, IGF-1, VEGFA, AFGF, BFGF)
1. EGF (sh‑Oligopeptide‑1)
Epidermal Growth Factor (EGF) binds to the EGF receptor (EGFR) on keratinocytes and dermal fibroblasts, thereby promoting cell survival, proliferation, migration, and differentiation. Clinical/interface data show topical EGF can accelerate re‑epithelialization, improve skin texture, and reduce signs of ageing. In the context of wrinkle reduction, activating fibroblasts and improving collagen matrix synthesis address one of the core deficits of aged skin. Source.
2. IGF‑1 (sh‑Oligopeptide‑2)
Insulin‑like Growth Factor‑1 (IGF‑1) signaling in skin has been shown to decline with age; lower IGF‑1 is associated with epidermal atrophy and increased keratinocyte damage. By supplying a bio‑mimetic analog of IGF‑1, the formulation supports fibroblast anabolic activity, enhances ECM production, and may improve dermal thickness—key for wrinkle amelioration. Source.
3. VEGFA (sh‑Polypeptide‑9)
Vascular Endothelial Growth Factor A (VEGFA) is essential for angiogenesis and the maintenance of the skin microvasculature; evidence shows that VEGFA signaling enhances nutrient and oxygen delivery, supporting fibroblast viability and extracellular matrix turnover, making it a key target in skin rejuvenation therapies.
4. AFGF (sh‑Polypeptide‑11)
Acidic Fibroblast Growth Factor (aFGF) has been implicated in dermal repair and regeneration in the wound-healing literature; although less direct in aesthetic dermatology, its inclusion supports fibroblast proliferation and collagen/elastin synthesis in synergy with other growth factors.
5. BFGF (sh‑Polypeptide‑1)
Basic Fibroblast Growth Factor (bFGF) similarly acts on dermal fibroblasts, promoting collagen and glycosaminoglycan (GAG) production. Its role in enhancing dermal matrix density complements the overall strategy of restoring skin structural integrity.
Biomimetic Peptides for Skin Repair (GHK-Cu, AHP, Phyto-NEP)
These lab-engineered peptides replicate signals naturally found in the skin, enhancing its ability to repair and rebuild.
GHK-Cu (Copper Tripeptide-1)
A potent skin-regenerating peptide that boosts collagen, elastin, and glycosaminoglycan production. Source.
AHP (Acetyl Hexapeptide-8)
Often referred to as a “topical Botox mimic”, AHP reduces the appearance of expression lines by relaxing facial tension.
Phyto-NEP (Caffeoyl sh-Decapeptide-9)
A plant-derived peptide that enhances skin defense mechanisms and promotes a smoother texture.
Supporting Actives — Hyaluronic Acid, Adenosine, PDRN
These compounds complement the growth factors and peptides, helping create a healthy environment for regeneration.
Low‑Molecular‑Weight Hyaluronic Acid
Hydration and volume loss are intrinsic to skin ageing: low‑molecular‑weight hyaluronic acid penetrates more deeply, binds water, improves dermal turgor, and creates an optimal milieu for fibroblast activity.
Adenosine
Adenosine interacts with purinergic receptors in the dermis and epidermis, influencing collagen production and microcirculatory tone, and may improve wrinkle appearance in controlled studies.
PDRN (Polydeoxyribonucleotide)
Polydeoxyribonucleotide (PDRN) is a nucleic acid derivative that has been shown to accelerate fibroblast and keratinocyte proliferation, enhance angiogenesis, and improve dermal repair in skin models. Its incorporation provides a “regeneration priming” effect, supporting the actions of growth factors and peptides. Source.
Exosomes Skin Treatment Protocol — Synergistic Action
- Collagen and elastin production
- Cell turnover acceleration
- Improved hydration and barrier function
- Microcirculation enhancement
- Relaxation of dynamic lines
Who Uses Elevexo® S? Clinics, Med Spas & Aesthetic Practitioners
Elevexo® S is designed for use in medical aesthetics settings, including:
- Dermatology and anti-aging clinics
- Med spas with licensed professionals
- Post-procedural skin repair protocols
- Integration with microneedling, RF, or laser treatments
Clinical Use & Application
- Suggested use: Every 14-day application, with or without adjunct procedures
- Visible effects: Improved texture, tone, and hydration typically observed in 4–8 weeks
- Professional guidance recommended
- No systemic claims or permanent outcomes
Microneedling Serum Protocol — Elevexo® S as a Clinical Enhancer
Microneedling is one of the most widely used procedures in aesthetic practice, and pairing it with the right serum can significantly enhance its regenerative value. As a microneedling serum, Elevexo® S is designed to work alongside microneedling, RF microneedling, and laser resurfacing — procedures already referenced in the Clinical Use section of this page.
When applied pre- or post-procedure, Elevexo® S delivers growth factors and peptides into the skin at a time when absorption is optimised. Applied beforehand, it primes the skin with regenerative signals; applied afterward, it supports recovery and reinforces the treatment’s rejuvenating effects. This dual role makes the serum a flexible enhancer across a clinic’s existing device-based treatments, giving practitioners a straightforward way to elevate outcomes while supporting the skin’s natural healing response following controlled micro-injury.
Microneedling Aftercare Serum: Application Guide for Clinics
As a microneedling aftercare serum, Elevexo® S is applied by clinic staff once the procedure is complete. After cleansing the treated area, the serum is applied evenly across the skin, allowing the active signals to absorb through the micro-channels created during treatment. Clinics should incorporate application into their standard post-procedure routine and provide patients with clear aftercare guidance to protect and support the skin during the initial recovery period
Results
Clinical Results — Skin Rejuvenation Treatment Before & After
Standard protocol: Two treatments separated by four weeks. Results shown at 60 days post first treatment.
